Contents
Cardiovascular & Hematological Disorders-Drug Targets , Volume 9 - Number 1
Promising Therapies in Sickle Cell Disease
, 9(1): 1 - 8Radha Raghupathy and Henny H. Billett
DOI: 10.2174/187152909787581354
Von Willebrand Factor: Drug and Drug Target
, 9(1): 9 - 20Simon F. De Meyer, Bauke De Maeyer, Hans Deckmyn and Karen Vanhoorelbeke
DOI: 10.2174/187152909787581327
Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
, 9(1): 21 - 28Massimo Breccia and Giuliana Alimena
DOI: 10.2174/187152909787581363
Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure
, 9(1): 29 - 35Luigi Mancuso, Andrea Mancuso, Elvira Bevacqua and Paolo Rigano
DOI: 10.2174/187152909787581345
Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
, 9(1): 36 - 50Paul Coppo and Agnes Veyradier
DOI: 10.2174/187152909787581318
Chromatin Structure and Epigenetics of Tumour Cells: A Review
, 9(1): 51 - 61Eva Bartova, Jana Krejci, Roman Hajek, Andrea Harnicarova and Stanislav Kozubek
DOI: 10.2174/187152909787581336
Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells
, 9(1): 62 - 77Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova and Ivan Spicka
DOI: 10.2174/187152909787581372
Webmaster Contact: info@benthamscience.org